- Home
- ECAT
as 11-14-2025 3:41pm EST
BlackRock ESG Capital Allocation Trust is a non-diversified, closed-ended management investment company. The Trust's investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation.
| Founded: | 2021 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 1.6B | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 278.6K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Monthly | |
| EPS: | 2.39 | EPS Growth: | N/A |
| 52 Week Low/High: | $14.02 - $17.30 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of BlackRock ESG Capital Allocation Term Trust of Beneficial Interest (ECAT)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Saba Capital Management, L.P. | ECAT | 10% Owner | Nov 11 '25 | Sell | $16.39 | 39,740 | $651,338.60 | 27,060,227 | |
| Saba Capital Management, L.P. | ECAT | 10% Owner | Nov 10 '25 | Sell | $16.28 | 17,653 | $287,390.84 | 27,060,227 | |
| Saba Capital Management, L.P. | ECAT | 10% Owner | Nov 6 '25 | Sell | $16.10 | 57,053 | $918,553.30 | 27,060,227 | |
| Saba Capital Management, L.P. | ECAT | 10% Owner | Nov 5 '25 | Sell | $16.30 | 49,369 | $804,714.70 | 27,060,227 | |
| Saba Capital Management, L.P. | ECAT | 10% Owner | Nov 4 '25 | Sell | $16.30 | 3,600 | $58,680.00 | 27,060,227 | |
| Saba Capital Management, L.P. | ECAT | 10% Owner | Nov 3 '25 | Sell | $16.40 | 70,661 | $1,158,840.40 | 27,060,227 | |
| Saba Capital Management, L.P. | ECAT | 10% Owner | Oct 31 '25 | Sell | $16.42 | 24,045 | $394,818.90 | 27,060,227 | |
| Saba Capital Management, L.P. | ECAT | 10% Owner | Oct 30 '25 | Sell | $16.46 | 78,022 | $1,284,242.12 | 27,060,227 | |
| Saba Capital Management, L.P. | ECAT | 10% Owner | Oct 29 '25 | Sell | $16.55 | 75,953 | $1,257,022.15 | 27,060,227 | |
| Saba Capital Management, L.P. | ECAT | 10% Owner | Oct 28 '25 | Sell | $16.64 | 1,200 | $19,968.00 | 27,060,227 |
Latest BlackRock ESG Capital Allocation Term Trust of Beneficial Interest News
ECAT Breaking Stock News: Dive into ECAT Ticker-Specific Updates for Smart Investing
Business Wire
16 days ago
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
Business Wire
a month ago
Certain BlackRock Closed-End Funds Provide Updates on their Discount Management Programs
Business Wire
7 months ago
Certain BlackRock Closed-End Funds Announce Tender Offer in Conjunction with Results of the Quarterly Measurement Period of their Discount Management Programs
Business Wire
a year ago
Distribution Dates and Amounts Announced for ECAT, BCAT, BMEZ, BSTZ and BIGZ
Business Wire
a year ago
Certain BlackRock Funds Announce Final Results of Tender Offers
Business Wire
a year ago
Certain BlackRock Funds Announce Expiration and Preliminary Results of Tender Offers
Business Wire
a year ago
Saba Capital Corrects BlackRock’s Intentionally False and Misleading 2024 Annual Meeting Results
Business Wire
a year ago
U.S. Court of Appeals for the Second Circuit Reaffirms Ruling That Certain Closed-End Funds, Including Funds Advised by BlackRock, Violated the Investment Company Act of 1940
Compare ECAT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ECAT BlackRock ESG Capital Allocation Term Trust of Beneficial Interest - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.